ATNM

Actinium Pharmaceuticals (Delaware) (ATNM)

About Actinium Pharmaceuticals (Delaware) (ATNM)

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.

Details

Daily high

$1.45

Daily low

$1.27

Price at open

$1.40

52 Week High

$10.24

52 Week Low

$1.03

Market cap

43.1M

Dividend yield

0.00%

Volume

320,388

Avg. volume

1.2M

P/E ratio

-1.08

Actinium Pharmaceuticals (Delaware) News